ArticleIEEE transactions on medical imaging2019
Hyperspectral Tissue Image Segmentation Using Semi-Supervised NMF and Hierarchical Clustering.
Article in IEEE transactions on medical imaging, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
7 citing papers in PubMed, 1 synthesis or guideline pooled it.
- Medical hyperspectral imaging: an updated review of technology advancements and biomedical applications.Journal of biomedical optics · 2026Pooled it
- USSGAN: Unsupervised Spectral and Spatial Attention-Based Generative Adversarial Network for Cholangiocarcinoma Detection.Chemical & biomedical imaging · 2025Article
- Exploring Radiomics Features Based on H&E Images as Potential Biomarkers for Evaluating Muscle Atrophy: A Preliminary Study.Journal of imaging informatics in medicine · 2024Article
- Article
- Generative adversarial network based digital stain conversion for generating RGB EVG stained image from hyperspectral H&E stained image.Journal of biomedical optics · 2023Article
- RCTE: A reliable and consistent temporal-ensembling framework for semi-supervised segmentation of COVID-19 lesions.Information sciences · 2021Article
- FSS-2019-nCov: A deep learning architecture for semi-supervised few-shot segmentation of COVID-19 infection.Knowledge-based systems · 2021Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
Abstract
Hyperspectral imaging (HSI) of tissue samples in the mid-infrared (mid-IR) range provides spectro-chemical and tissue structure information at sub-cellular spatial resolution. Disease states can be directly assessed by analyzing the mid-IR spectra of different cell types (e.g., epithelial cells) and sub-cellular components (e.g., nuclei), provided that we can accurately classify the pixels belonging to these components. The challenge is to extract information from hundreds of noisy mid-IR bands at each pixel, where each band is not very informative in itself, making annotations of unstained tissue HSI images particularly tricky. Because the tissue structure is not necessarily identical between the two sections, only a few regions in unstained HSI image can be annotated with high confidence, even when serial (or adjacent) hematoxylin and eosin stained section is used as a visual guide. In order to completely use both labeled and unlabeled pixels in training images, we have developed an HSI pixel classification method that uses semi-supervised learning for both spectral dimension reduction and hierarchical pixel clustering. Compared to the supervised classifiers, the proposed method was able to account for the vast differences in the spectra of sub-cellular components of the same cell type and to achieve an F1 score of 71.18% on twofold cross-validation across 20 tissue images. To generate further interest in this promising modality, we have released our source code and also showed that disease classification is straightforward after HSI image segmentation.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.